Immunocore Holdings plc
IMCR
$30.36
-$0.37-1.20%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.46% | -102.03% | 11.33% | 120.56% | -20.48% |
| Total Depreciation and Amortization | -28.47% | -22.90% | -21.37% | -15.53% | 12.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 81.00% | 43.62% | 27.30% | -79.73% | -39.67% |
| Change in Net Operating Assets | -512.47% | -107.35% | -1.79% | -193.49% | 78.64% |
| Cash from Operations | -134.07% | -121.09% | 10.62% | 109.48% | 21.33% |
| Capital Expenditure | 19.64% | 9.66% | -25.08% | 30.70% | -338.68% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 91.43% | -- | -- |
| Cash from Investing | 75.14% | 734.30% | 91.32% | 2,356.28% | -333.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 678.91% | 842.42% | 1,131.54% | -55.67% | -91.21% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 108.32% | 842.42% | 548.66% | -99.36% | -923.65% |
| Foreign Exchange rate Adjustments | 88.85% | -36.36% | 7,564.15% | 1,153.25% | -220.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 62.57% | -68.03% | 103.38% | -94.59% | -5,325.66% |